Open Access
- 14 July 2009
- journal article
- review article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 7 (1) , 70
Abstract
Preeclampsia is a leading cause of maternal and fetal/neonatal mortality and morbidity worldwide. The early identification of patients with an increased risk for preeclampsia is therefore one of the most important goals in obstetrics. The availability of highly sensitive and specific physiologic and biochemical markers would allow not only the detection of patients at risk but also permit a close surveillance, an exact diagnosis, timely intervention (e.g. lung maturation), as well as simplified recruitment for future studies looking at therapeutic medications and additional prospective markers. Today, several markers may offer the potential to be used, most likely in a combinatory analysis, as predictors or diagnostic tools. We present here the current knowledge on the biology of preeclampsia and review several biochemical markers which may be used to monitor preeclampsia in a future, that, we hope, is not to distant from today.Keywords
This publication has 200 references indexed in Scilit:
- The Two Stage Model of Preeclampsia: Variations on the ThemePlacenta, 2009
- Differential placental gene expression in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- First-trimester maternal serum PP13 in the risk assessment for preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass SpectrometryMolecular & Cellular Proteomics, 2008
- Circulating and Placental Endoglin Concentrations in Pregnancies Complicated by Intrauterine Growth Restriction and PreeclampsiaPlacenta, 2008
- First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm deliveryUltrasound in Obstetrics & Gynecology, 2008
- Antiplatelet agents for preventing pre-eclampsia and its complicationsCochrane Database of Systematic Reviews, 2007
- The level of ADAM12-S in maternal serum is an early first-trimester marker of fetal trisomy 18Prenatal Diagnosis, 2005
- Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2004
- Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant womenAmerican Journal of Obstetrics and Gynecology, 2004